Skip to main content

Table 2 Postoperative outcome

From: Tissue oxygenation as a target for goal-directed therapy in high-risk surgery: a pilot study

 

Control (n = 20)

Intervention (n = 20)

P-value*

Dobu+(n = 10)

P-value§

Number of complications (n)

20

11

0.23

7

0.49

Patients without complications (n)

7

11

0.34

4

1.00

Complications

  

0.35

 

0.56

 Pneumonia

4

5

 

3

 

 Respiratory failure

1

    

 Cardiac failure

 

1

 

1

 

 Supraventricular arrhythmia

3

1

   

 Relaparotomy

1

1

 

1

 

 Ileus

3

1

 

1

 

 Urinary tract infection

2

1

 

1

 

 Renal failure

1

    

 TIA

1

    

 Delirium

4

    

 Hematoma

1

    

 Death

 

1

   

SOFA score

5 [2-12]

6 [5-11]

0.73

5 [5-9]

0.78

TISS score

25 [21–33]

26 [22–30]

0.95

28 [26–48]

0.96

LOS ICU (hours)

22 [21–45] (n = 15)

22 [17–38] (n = 15)

0.53

22 [17–43] (n = 8)

0.50

LOS PACU (hours)

18 [17-22] (n = 5)

18 [13-22] (n = 5)

0.75

17 [17,18] (n = 2)

0.42

LOS FFD (hours)

18 [8–37]

17 [6-23]

0.39

18 [13–36]

0.70

LOS Hosp (days)

12 [9-17]

13 [7-17]

0.96

15 [8-25]

0.72

  1. Dobu+, subgroup of intervention subjects that did receive dobutamine; SOFA, sequential organ failure assessment; TIA, transient ischemic attack; LOS, length of stay; ICU, intensive care unit; PACU, post anesthesia care unit; FFD, fit for discharge; Hosp, hospital; *Control versus Intervention; § Control versus Dobu+.